Top Read Articles

    Published in last 1 year |  In last 2 years |  In last 3 years |  All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Progress in diagnosis and treatment of primary mediastinal large B-cell lymphoma
    CAI Lu, YI Hongmei, WANG Chaofu
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 490-494.   DOI: 10.16138/j.1673-6087.2025.06.11
    Abstract306)   HTML5)    PDF(pc) (452KB)(333)       Save

    Primary mediastinal large B-cell lymphoma (PMBCL) is an aggressive non-Hodgkin lymphoma originating from thymic B cells. It typically presents as a rapidly growing anterior mediastinal mass, often accompanied by local symptoms such as chest tightness and shortness of breath, as well as systemic symptoms like fever and night sweats. R-CHOP (rituximab + cyclophosphamide + doxorubicin + vincristine + prednisone) and R-EPOCH (etoposide + prednisone + vincristine + cyclophosphamide + doxorubicin + rituximab) are the commonly used first-line treatments. Formulating precise diagnostic and therapeutic strategies requires a comprehensive understanding of its unique clinical, pathological, and molecular characteristics. This review delivers a comprehensive overview of the clinical features, pathological characteristics, molecular mechanisms, differential diagnosis, and recent advances in treatment of PMBCL, aiming to provide a reference for accurate diagnosis, optimized patient management, and improved therapeutic outcomes.

    Reference | Related Articles | Metrics | Comments0
    Construction of sensitivity indicators for perioperative nursing quality in percutaneous coronary intervention
    WU Shengjia, HUANG Sichao, KANG Lei, ZHU Weiyi, ZHA Qinghua, NI Xueping
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 469-476.   DOI: 10.16138/j.1673-6087.2025.06.07
    Abstract295)   HTML3)    PDF(pc) (550KB)(192)       Save

    Objective To develop a scientifically reasonable set of sensitivity indicators for perioperative nursing quality in percutaneous coronary intervention (PCI). Methods Domestic and international literature was retrieved, and the Johns Hopkins evidence-based nursing practice model was employed to appraise the literature and grade the evidence. Indicators were screened and integrated to form a preliminary pool of sensitivity indicators for PCI perioperative nursing quality. Based on the theoretical basis of the Donabedian three-dimensional quality model, the Delphi method was utilized for expert consultation to construct the final indicator set. Results The response rates for both rounds of the expert consultation were 100%. The expert authority coefficients were both 0.889. The overall Kendall’ s coefficient of concordance were 0.496 and 0.523, respectively (P < 0.001). The final set of PCI perioperative nursing quality sensitivity indicators comprises 3 first-level, 13 second-level and 36 third-level indicators.Conclusions The developed sensitivity indicators for PCI perioperative nursing quality encompass multiple dimensions, including human resources, management systems, medical specialty training, nursing competency, medication and facility management, health education, preoperative/intraoperative/postoperative management, patient satisfaction, incidence of adverse events, nursing efficiency, and continuity of care. This indicator system can comprehensively measure PCI perioperative nursing quality and serves as a valuable tool for improving the overall standard of PCI perioperative nursing services.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Development of a questionnaire on adult artificial airway management competence for ICU nurses and tests of its reliability and validity
    CHEN Hui, ZHANG Yin, QIAN Zhuping, YAO Yijin
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 462-468.   DOI: 10.16138/j.1673-6087.2025.06.06
    Abstract258)   HTML1)    PDF(pc) (525KB)(185)       Save

    Objective To develop a questionnaire on adult artificial airway management competence for intensive care unit (ICU) nurses. Methods A preliminary questionnaire on the competence of ICU nurses in managing adult artificial airways was formulated through literature review, Delphi expert consultation and a pilot survey. Using convenience sampling, 366 ICU nurses from two tertiary grade A hospitals in Shanghai and Harbin were surveyed from April to June 2024. Item analysis, exploratory factor analysis, confirmatory factor analysis and reliability test were conducted. Results The final questionnaire consisted of 32 items across 4 dimensions: artificial airway suctioning, endotracheal tube cuff management, prevention of artificial airway complications and artificial airway extubation care. Exploratory factor analysis extracted four common factors, with item factor loadings ranging from 0.403 to 0.968, and the cumulative variance contribution rate was 68.97%. Confirmatory factor analysis results showed that the model fit indices met acceptable standards, indicating a stable questionnaire structure. The overall content validity index of the questionnaire was 1.00, the total Cronbach's α coefficient was 0.98, the split-half reliability was 0.93, and the test-retest reliability was 0.99. Conclusions The questionnaire on adult artificial airway management competence for ICU nurses demonstrates good reliability and validity, and can be used as a tool to evaluate the corresponding competence of ICU nurses.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Roxadustat-induced central hypothyroidism in hemodialysis patients: a report of two cases
    XIA Yumiao, FU Peng, WU Hao
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 487-489.   DOI: 10.16138/j.1673-6087.2025.06.10
    Abstract254)   HTML3)    PDF(pc) (449KB)(350)       Save

    Hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) is a novel class of oral medications for treating renal anemia, but adverse drug events have been reported both in China and internationally in recent years. This article reports two cases of reversible central hypothyroidism following the administration of the HIF-PHI roxadustat in patients undergoing regular hemodialysis with end-stage renal disease. Both patients gradually developed non-specific discomfort symptoms after one year of oral roxadustat treatment. Laboratory tests revealed abnormal thyroid function, while cranial magnetic resonance imaging showed no abnormalities. After discontinuation of roxadustat, thyroid function returned to normal and the symptoms resolved. These two cases suggest that it is necessary to monitor thyroid function in patients receiving oral roxadustat for renal anemia.

    Reference | Related Articles | Metrics | Comments0
    Clinical characteristic and treatment progress of neurologic immune-related adverse events associated with immune checkpoint inhibitors
    XIE Chong, WAN Wenbin, YAO Xiaoying, ZHANG Ying, WANG Gang
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 359-364.   DOI: 10.16138/j.1673-6087.2025.05.02
    Abstract237)   HTML10)    PDF(pc) (479KB)(251)       Save

    In recent years, immune checkpoint inhibitor (ICI) has achieved remarkable success in cancer therapy. However, the occurrence of immune-related adverse event (irAE) has increasingly attracted attention. Among them, neurologic immune-related adverse event (n-irAE) is relatively uncommon, but can cause severe outcomes. n-irAE can involve multiple regions of the nervous system, including the peripheral nerves, neuromuscular junction, and central nervous system (CNS), and lead to myositis, myasthenia gravis, encephalitis, myelitis, and other disorders. The diagnosis of n-irAE requires a combination of evaluating the time correlation between symptoms and ICI medication, neurological localization assessments (neuroimaging, cerebrospinal fluid analysis, and electrophysiological studies), and the exclusion of alternative etiologies such as metastatic disease or infection. n-irAE is graded and treated based on clinical severity, and the common therapeutic approaches include corticosteroids, intravenous immunoglobulin, and plasma exchange. Multidisciplinary collaboration and early intervention are crucial for improving patient outcomes. Future efforts should focus on optimizing risk prediction models to achieve individualized management of n-irAE.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Sodium-glucose linked transporter 2 inhibitors reduce serum uric acid in type 2 diabetic mellitus patients with early nephropathy
    WU Qianqian, GUO Jie, WANG Yifan, LIU Li, WANG Feng
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 371-375.   DOI: 10.16138/j.1673-6087.2025.05.04
    Abstract224)   HTML9)    PDF(pc) (503KB)(238)       Save

    Objective To explore the reducing serum uric acid (SUA) effects of dapagliflozin, a sodium-glucose linked transporter 2 (SGLT2) inhibitor in patients with type 2 diabetes mellitus (T2DM) with early nephropathy and hyperuricemia. Methods Sixty-five patients with early T2 diabetic nephropathy and hyperuricemia admitted to our hospital from June 2020 to June 2023 were enrolled. After 4 weeks of treatment with dapagliflozin, a paired-sample T-test was used to analyze the changes in SUA, glycosylated hemoglobin (HbA1c), fasting plasma glucose (FPG), serum creatinine (SCr), total cholesterol (TC), triglyceride (TG), urine albumin-to-creatinine ratio (UACR), body weight and other clinical indexes. Linear regression analysis was performed to determine the relationship between the changes of SUA before (baseline) and after treatment. Results In this group of 65 T2DM patients with early nephropathy and hyperuricemia, 4 weeks of dapagliflozin reduced SUA [(436.1±39.5)vs (392.2±32.2) μmol/L,P<0.001], FPG [(7.66±2.23)vs (6.40±1.06) mmol/L,P<0.001], UACR [(211.3±73.2)vs (177.8±88.3) mg/g,P=0.005], and body weight [(63.1±9.7)vs (62.7±9.3) kg,P=0.038] significantly. Systolic blood pressure, diastolic blood pressure, HbA1c, TC, TG, SCr, estimated glomerular filtration rate (eGFR), and other levels were not changed (P>0.05). Linear regression analysis showed that the decreased levels of SUA positively correlated with the baseline levels of SUA (β=0.634,R2=0.401,P<0.001). Conclusions SGLT2 could effectively decrease blood glucose levels in patients with early T2DM nephropathy, and significantly reduce serum uric acid and urinary microalbumin.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Advances in diagnosis and treatment of radiation-induced brain injury
    HUANG Renhua, BAI Yongrui
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 352-358.   DOI: 10.16138/j.1673-6087.2025.05.01
    Abstract212)   HTML9)    PDF(pc) (482KB)(383)       Save

    Radiation-induced brain injury is a common complication after radiotherapy for head and neck tumors. It can occur at any time after radiotherapy. The common sites are closely related to the radiotherapy regimen and are more frequently seen in areas receiving the highest radiotherapy dose. Early symptoms include fatigue, dizziness and headaches. In the later stage, epileptic seizures, personality changes and progressive decline in neurocognitive function may occur. Brain computed tomography (CT) often shows focal low-density images, and brain magnetic resonance imaging (MRI) presents with “finger-like” edema in the white matter of the brain during the edema stage. The use of multimodal MRI, positron emission tomography (PET) and other imaging techniques can help to make early diagnosis and differential diagnosis of radiation-induced brain injury. The treatment options include medication, hyperbaric oxygen therapy, surgery and mesenchymal stem cell transplantation. Commonly used drugs in clinical practice include bevacizumab, dexamethasone, citicoline and gangliosides. With the increasing attention paid to radiation-induced brain injury, the research on related mechanisms has been continuously deepened and the corresponding therapeutic drugs have achieved good therapeutic effects. However, effective prevention is more important than treatment. As the brain has complicated structure and functions, damage to functional areas can lead to disability or even death. Optimizing radiotherapy techniques can achieve precise irradiation of tumors and reduce the volume of normal brain tissue exposed to radiation. Radiotherapy plans should be formulated based on factors such as the patient’s age, underlying diseases, and tumor location to avoid excessive exposure to radiation-sensitive areas. Using hippocampal protective radiotherapy to reduce the radiation dose to the hippocampal region can significantly decrease the risk of memory decline and allow the reasonable control of the radiotherapy. The diagnosis and treatment of radiation-induced brain injury is a multidisciplinary collaborative process. It is necessary to strengthen the full life cycle management of patients with head and neck tumors undergoing radiotherapy. Through technological innovation and individualized treatment, the incidence and harm of brain injury should be further reduced.

    Reference | Related Articles | Metrics | Comments0
    Mechanisms of frailty in postmenopausal women and the role of menopausal hormone therapy
    MU Rui, JIANG Jie, RAHMAN Mukadas, TONG Jianjing
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 505-509.   DOI: 10.16138/j.1673-6087.2025.06.14
    Abstract212)   HTML5)    PDF(pc) (469KB)(267)       Save

    Frailty is an age-related geriatric syndrome characterized by multisystem functional decline, which increases vulnerability to external stressors and raises the risk of adverse health outcomes. Epidemiological studies indicate a higher prevalence of frailty in women than in men, significantly influenced by the abrupt decline in estrogen levels after menopause, leading to deterioration in skeletal, muscular, metabolic, and immune functions. As an approach to postmenopausal management, menopausal hormone therapy (MHT) remains to have a debated impact on frailty risk. Studies show that MHT has demonstrated clear benefits on frailty-related physiological indicators; however, its overall efficacy in frailty prevention requires further validation through high-quality studies. This review summarizes current evidence linking menopause and frailty, with a focus on the role and limitations of MHT. Future research should focus on personalized treatment strategies, effects of combined intervention, and the role of psychosocial factors in frailty management.

    Reference | Related Articles | Metrics | Comments0
    Anti-inflammatory effects and safety evaluation of decursin in atherosclerosis
    CHEN Hui, YANG Ling, ZHAO Anqi, ZHA Qing, YANG Ke, LIU Yan
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 457-461.   DOI: 10.16138/j.1673-6087.2025.06.05
    Abstract200)   HTML5)    PDF(pc) (867KB)(204)       Save

    Objective To investigate the anti-inflammatory effects and safety of decursin in atherosclerosis, and to verify its regulatory role in macrophage inflammatory responses. Methods An atherosclerosis model was established using apolipoprotein E deficient (ApoE-/-) male mice fed a high-fat diet. RAW 264.7 macrophages were stimulated with oxidized low-density lipoprotein (oxLDL) to induce foam cell formation. Oil Red O (ORO) staining was employed to measure the reduction in aortic plaque area. Western blotting was performed to detect the phosphorylation levels of nuclear factor-κB (NF-κB). Inflammatory cytokine levels in serum and cell supernatants were analyzed using inflammatory cytokine arrays. Systemic toxicity of decursin was assessed by hematoxylin-eosin (HE) staining. Results Decursin significantly reduced aortic plaque area and inhibited the excessive activation of NF-κB in oxLDL-stimulated macrophages. It downregulated the expression of pro-inflammatory cytokines [interleukin (IL)-2 and interferon (IFN)-γ] while upregulating anti-inflammatory cytokines (IL-4 and IL-10). Furthermore, in the ApoE-/- mouse model, decursin similarly significantly lowered serum levels of pro-inflammatory cytokines and elevated those of anti-inflammatory cytokines. HE staining results showed that decursin caused no obvious pathological damage to major organs.Conclusions Decursin exerts significant anti-inflammatory effects by regulating macrophage inflammatory responses, alleviates atherosclerotic lesions, and demonstrates a high safety profile, suggesting its potential as a therapeutic agent for atherosclerosis.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Relationship between triglyceride-glucose index and risk of acute myocardial infarction in patients with atrial fibrillation
    CHEN Liangguo, DENG Kewu, LIU Yue, ZHONG Peng, BAI Ying
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 435-439.   DOI: 10.16138/j.1673-6087.2025.06.02
    Abstract195)   HTML9)    PDF(pc) (529KB)(208)       Save

    Objective To explore the relationship between triglyceride-glucose (TyG) index and the occurrence of acute myocardial infarction (AMI) in patients with atrial fibrillation (AF). Methods A total of 4 277 hospitalized AF patients from Beijing Tongren Hospital and Beijing Friendship Hospital affiliated to Capital Medical University were enrolled. They were divided into a non-AMI group [AMI(−), 3 725 cases] and an AMI group [AMI(+), 552 cases] based on whether they were admitted for AMI. Logistic regression was used to assess the association between the TyG index and AMI, and subgroup analyses were performed according to the presence of diabetes at baseline. Results Among AF patients, the TyG index was significantly higher in the AMI(+) group than in the AMI(−) group (8.83 ± 0.73 vs. 8.56 ± 0.66, P < 0.001). Additionally, patients in the AMI(+) group were older and had more comorbidities (both P < 0.05). Multivariate Logistic regression showed that high TyG index was an independent risk factor for AMI in AF patients [odds ratio(OR) = 1.824, 95%CI 1.540−2.161, P < 0.001], and the area under the receiver operating characteristic (ROC) curve for the TyG index in predicting AMI was 0.614 (95%CI 0.589−0.640, P < 0.001), with a cut-off value of 8.79. In AF patients, the TyG index was positively associated with the risk of AMI regardless of the presence of diabetes. Conclusions The TyG index is positively associated with the risk of AMI in AF patients, which is not affected by diabetes status.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Progress in noninvasive assessment of cardiac amyloidosis
    ZHANG Maosen, CHE Zigang, GUO Wanhua, ZHONG Yeming, FENG Chengyan, WEI Xuan
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 495-499.   DOI: 10.16138/j.1673-6087.2025.06.12
    Abstract194)   HTML12)    PDF(pc) (466KB)(247)       Save

    Amyloidosis is a group of disorders caused by misfolded proteins that deposit in tissues and impair the function of vital organs. Systemic amyloidosis frequently involves the heart and is a leading cause of death in affected patients. Cardiac amyloidosis is difficult to diagnose and carries a poor prognosis, making early diagnosis and assessment crucial for treatment and prognosis. This article reviews several noninvasive techniques for diagnosing and evaluating cardiac amyloidosis.

    Reference | Related Articles | Metrics | Comments0
    How to accurately understand and define early diagnosis of chronic obstructive pulmonary disease
    HE Quanying
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 431-434.   DOI: 10.16138/j.1673-6087.2025.06.01
    Abstract193)   HTML8)    PDF(pc) (412KB)(216)       Save

    This article discusses the challenges in the early diagnosis of chronic obstructive pulmonary disease (COPD) in light of the 2024 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report. It analyzes and distinguishes between the concepts such as “early COPD” and “pre-COPD”, noting their differences in meaning from practical early diagnosis. Currently, early diagnosis faces difficulties in identifying high-risk individuals, determining disease onset, and assessing the stability of pulmonary function results. Therefore, the author argues that priority should be given to improving the overall diagnostic rate of COPD, and suggests that standardized pulmonary function screening for high-risk populations, combined with long-term management, represents the most feasible early intervention method at present.

    Reference | Related Articles | Metrics | Comments0
    Exploring and practicing “integrated residency and fellowship teaching rounds” in neurology
    YANG Xiaodong, TAN Yuyan, REN Rujing, FU Yi, LIU Jun, LI Xiaoyang
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 510-514.   DOI: 10.16138/j.1673-6087.2025.06.15
    Abstract186)   HTML2)    PDF(pc) (471KB)(220)       Save

    The standardized fellowship and the standardized residency training are important components of China's post-graduation medical education system. According to the national guidelines for standardized fellowship, it is necessary to establish a structured training system, which, together with residency training, forms a complete educational system. Therefore, further exploration is needed on effective integration of residency and fellowship in medical education and training, optimal utilization of teaching resources and faculty at training sites, and the establishment of teaching models that promote the coordinated development of resident and specialist training. The Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, has proposed and implemented an “integrated residency and fellowship teaching round model”, which involves specialists mentoring residents, facilitating mutual learning and professional growth for both groups. This article introduces the model with an aim to further enrich the content of fellowship and residency training, improve training quality, so as to comprehensively enhance the clinical teaching abilities of specialists and provide a reference for innovating postgraduate medical education models.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Discussion on effect and mechanism of hypoglycemic drugs on Parkinson disease
    ZHANG Haihan, JING Wei, SHAN Yuetong, ZHANG Yuling, CHEN Anan, LONG Siqi, WANG Yuze, LI Wei, PAN Weidong
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 399-404.   DOI: 10.16138/j.1673-6087.2025.05.10
    Abstract179)   HTML2)    PDF(pc) (486KB)(387)       Save

    Parkinson disease (PD) is a chronic neurodegenerative disease, and the pathgenesis is mainly related to neuronal degeneration and abnormal accumulation of αSyn. Some studies have shown that patients with PD are more likely to suffer from type 2 diabetes mellitus. Hypoglycemic drugs regulate blood glucose through modulating glucose metabolism and improving insulin sensitivity. Some of hypoglycemic drugs also have neuroprotective or antioxidant effect, and their mechanisms of action in neurodegenerative diseases have been extensively studied in recent years. This article reviews the pathological basis and related pathogenesis of PD, exploring the effect of hypoglycemic drugs on the progression of PD.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Analysis of current status and influencing factors of opportunistic infections in Crohn disease
    CAI Hui, LI Yousheng, HUANG Yuhua, XU Jingjing, LIU Qingfen, GU Fen
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 440-448.   DOI: 10.16138/j.1673-6087.2025.06.03
    Abstract160)   HTML2)    PDF(pc) (551KB)(182)       Save

    Objective To explore the current status and influencing factors of opportunistic infections in Crohn disease. Methods Data on demographic characteristics, disease features, treatment regimens and laboratory results of 369 patients with Crohn disease admitted to a tertiary grade A hospital in Shanghai from January 2020 to August 2024 were retrospectively collected. Univariate analysis and multivariate Logistic regression were employed to identify the influencing factors of opportunistic infections in Crohn disease. Results The incidence of opportunistic infections in patients with Crohn disease was 32.25%. Specifically, the incidence rates of viral infections, bacterial infections, and multiple infections were 16%, 12.2%, and 3.8%, respectively. Multivariate Logistic regression analysis showed that low disease activity [odds ratio (OR)=3.22, 95% CI: 1.18−8.81, P=0.023], moderate disease activity (OR=7.16, 95% CI: 1.88−27.31, P=0.004), albumin < 30 g/L (OR=4.99, 95% CI: 2.04−12.18, P < 0.001), and C-reactive protein > 10 mg/L (OR=3.70, 95% CI: 1.27−10.78, P=0.016) were independent risk factors for Crohn disease complicated with Epstein-Barr virus infection. A Charlson comorbidity index score of 1 (OR=5.01, 95% CI: 1.51−16.60, P=0.008), albumin < 30 g/L (OR=3.45, 95% CI: 1.23−9.72, P=0.019), and C-reactive protein >10 mg/L (OR=13.06, 95% CI: 2.46−69.40, P=0.003) were independent risk factors for Crohn disease complicated with latent mycobacterium tuberculosis infection. C-reactive protein >10 mg/L (OR=20.41, 95% CI: 2.13−195.52, P=0.009) was an independent risk factor for Crohn disease complicated with multiple infections. Conclusions Disease activity, co-existing chronic diseases, hypoalbuminemia, and elevated C-reactive protein levels are predictive factors for opportunistic infections in patients with Crohn disease. Active prevention as well as early diagnosis and treatment should be implemented for these patients at risk.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Research progress on peripheral neuropathy related to tumor immunotherapy
    ZHANG Yao, HAN Ting, WANG Yu, WANG Chunyan, XIAO Xiuying
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 388-392.   DOI: 10.16138/j.1673-6087.2025.05.08
    Abstract156)   HTML1)    PDF(pc) (456KB)(281)       Save

    With the rapid development of tumor immunotherapy, the widespread clinical application of immune checkpoint inhibitor (ICI) and chimeric antigen receptor T-cell (CAR-T) therapy has raised concerns about their associated neurotoxicity, which is known as neurologic immune-related adverse event (n-irAE). Immunotherapy significantly improves long-term survival rate of some patients by enhancing the host immune system’s ability to recognize and eliminate tumor cells. However, overactivation of the immune system can also lead to a range of immune-related adverse event (irAE) affecting non-tumor organs. Although neurological involvement is relatively uncommon, it is highly heterogeneous and can cause severe consequences. Peripheral neuropathy (PN) is one of the most important and potentially disabling manifestations. The clinical presentations of PN are diverse, including polyneuropathy, Guillain-Barré syndrome, radiculopathy, and sensory disturbances. The underlying pathogenesis is not fully understood but may involve immune dysregulation, autoantibodies, inflammatory cytokines, and individual genetic susceptibility. This review summarizes recent advances in the clinical features, pathogenesis, diagnosis, and treatment of PN associated with cancer immunotherapy, aiming to provide insights for early clinical recognition and intervention.

    Reference | Related Articles | Metrics | Comments0
    Renal manifestations of rheumatic autoimmune diseases
    ZHANG Xiaoyan, LI Huilin
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 410-414.   DOI: 10.16138/j.1673-6087.2025.05.12
    Abstract153)   HTML1)    PDF(pc) (456KB)(249)       Save

    Rheumatic autoimmune diseases are characterized by the involvement of multiple systems and organs, and the kidney is a common and critical target. The clinical manifestations of kidney diseases caused by different rheumatic diseases are diverse, ranging from asymptomatic hematuria and proteinuria to rapidly progressive glomerulonephritis and renal failure, and vary in severity. The treatment strategies and prognosis differ depending on the specific clinical manifestation. This article reviews relevant domestic and international literature, summarizing the renal manifestations associated with common rheumatic diseases. The aim is to improve clinicians’ understanding of the diseases, enabling them to intervene early to improve patient outcomes.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Advances in multidisciplinary integration and precision management of onco-neurological disorders
    WANG Gang, XIAO Xiuying
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 351-351.  
    Abstract151)   HTML16)    PDF(pc) (324KB)(210)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Advances in pathogenesis and treatment of chronic obstructive pulmonary disease complicated with sarcopenia
    WANG Yi, HUANG Hui
    Journal of Internal Medicine Concepts & Practice    2025, 20 (05): 415-419.   DOI: 10.16138/j.1673-6087.2025.05.13
    Abstract149)   HTML2)    PDF(pc) (468KB)(449)       Save

    Chronic obstructive pulmonary disease (COPD) is one of the most common chronic diseases of the respiratory tract, with a high mortality and disability rate. Sarcopenia is an important extrapulmonary manifestation in COPD patients, and its incidence rate is not low. The pathogenesis of COPD complicated with sarcopenia involves oxidative stress, systemic inflammatory response, autophagy, malnutrition and decreased physical activity, etc. Current research has shown that exercise intervention, nutritional support, and medication treatment can improve patients’ muscle strength and physical mobility, thereby enhancing patient prognosis. This article comprehensively reviews the pathogenesis and treatment of COPD complicated with sarcopenia, aiming to provide a valuable reference for disease research, diagnosis and treatment.

    Reference | Related Articles | Metrics | Comments0
    Efficacy and safety analysis of luspatercept in patients with myelodysplastic syndromes with ringsideroblasts and refractory anemia
    SONG Luxi, ZHANG Yumei, ZHANG Zheng, SU Jiying, ZHAO Youshan, WU Dong, HE Qi, WU Lingyun, CHANG Chunkang
    Journal of Internal Medicine Concepts & Practice    2025, 20 (06): 482-486.   DOI: 10.16138/j.1673-6087.2025.06.09
    Abstract141)   HTML4)    PDF(pc) (723KB)(268)       Save

    Objective To observe the clinical efficacy and safety of luspatercept in managing refractory anemia among patients with myelodysplastic syndrome with ring sideroblast (MDS-RS). Methods A retrospective analysis was performed on consecutive MDS-RS patients with refractory anemia who were treated with luspatercept at Department of Hematology, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine between August 2022 and December 2023. Eligible patients met the 2016 WHO diagnostic criteria for MDS-RS and were in the very low-, low-, or intermediate- risk groups according to the revised International Prognostic Scoring System (IPSS-R). Luspatercept was administered per label instructions, and a consistent transfusion strategy was required for each patient before and during treatment. Hematologic data and red blood cell transfusion episodes were recorded for each treatment cycle, and hematologic improvement (HI) was assessed using the revised International Working Group (IWG) 2018 criteria. Results 9 patients were enrolled. 7 patients achieved HI, among whom 5 achieved HI-erythroid (HI-E) and 2 achieved red blood cell transfusion independence (TI-RBC) for ≥8 weeks. The median duration of HI response was 17 (9−46) weeks. 5 of the 7 responding patients experienced loss of response, with a median time to first loss of 15 (9−23) weeks. During the study, impacted by the COVID-19 pandemic, 5 patients experienced 6 infection episodes. Treatment delays occurred 11 times in 6 patients, and all delays led to a decrease in hemoglobin [mean decrease, (18±6) g/L] or the need for red blood cell transfusions, directly resulting in 5 dose escalation and loss of response in 2 cases. 3 patients reported bone pain. 1 patient showed progression to grade 3 marrow fibrosis. 33.3% (3/9) reported bone pain, and 1 case showed progression to grade 3 marrow fibrosis. Conclusions This study confirms the real-world efficacy of luspatercept in patients with MDS-RS and refractory anemia. However, its efficacy is influenced by baseline transfusion burden and treatment delays, and depended on continuous and regular administration.

    Table and Figures | Reference | Related Articles | Metrics | Comments0